Company Overview of Inflabloc Pharmaceuticals, Inc.
Inflabloc Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development of pharmaceutical treatments for inflammatory disorders. The company develops fixed combination drug products that incorporate DHEA as a primary active ingredient. Inflabloc Pharmaceuticals, Inc. was formerly known as Pharmadigm, Inc. and changed the name to Inflabloc Pharmaceuticals, Inc. in 2004. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.
2150 West Dauntless Avenue
Salt Lake City, UT 84116
Founded in 1991
Key Executives for Inflabloc Pharmaceuticals, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Inflabloc Pharmaceuticals, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.